A Sandy, Utah clinic focused on stem cell therapy using donor umbilical cord and placental tissue, alongside peptide therapy and supporting modalities, with published prices.
Soma Health is a clinic at 9339 South 1300 East, Unit 108, in Sandy, Utah. Its website describes stem cell therapy as the clinic's central focus, offered alongside medically supervised peptide therapy, blood testing and several supporting in-clinic modalities. The site gives opening hours of Monday to Friday, 9am to 5pm.
According to the site, the material it calls stem cells is human mesenchymal stem cells from umbilical cord and placental tissue donated after full-term Caesarean births in Utah, processed and screened by an accredited United States tissue establishment. The site describes these as donor (allogeneic) perinatal tissue preparations and states they are not embryonic, not taken from the patient's own body, and not grown or multiplied in a laboratory. It also offers exosome preparations, which it describes as cell-free signalling vesicles that contain no cells. The site says treatment may be given intravenously or by targeted injection, with ultrasound guidance used when appropriate.
The site states that these preparations are investigational and not approved by the US Food and Drug Administration for orthopedic conditions, and that they are offered under Utah Code § 58-1-512, which sets conditions for licensed clinicians offering non-FDA-approved stem cell therapy for orthopedics, wound care or pain management. It says patients receive the Utah-required notice and sign written informed consent, and that the clinic does not guarantee any outcome.
Two things a reader may want to weigh. The medical director named on the site is a doctor of nursing practice and board-certified family nurse practitioner rather than a physician, and the pages reviewed name no supervising physician. The site also publishes no patient testimonials, saying it will only publish authorised ones, and no independent review rating could be verified for this listing.
The site has condition pages for the following areas.
The site states plainly that its cell product comes from donors rather than from the patient.
The site names three people.
The site describes a staged process: a free phone screening, then an in-person evaluation at the Sandy clinic, which it says is required before anyone can be considered a candidate. It says plans are often a series of treatments rather than a single injection, that another series is generally not considered within four to six months, and that function is reassessed at about three months.
The site publishes prices. The first phone consultation is free; the in-clinic provider consultation costs 197 United States dollars and is credited toward a care plan if the patient goes ahead; and single-joint care starts at 5,100 dollars for a 2 mL treatment, with the site noting some patients may need only 1 mL. It says the exact price is given in writing before anything is scheduled. Services are self-pay and not covered by insurance or Medicare; the clinic accepts HSA and FSA cards, offers financing through Cherry for those who qualify, and states that unused services are fully refundable. These figures are self-published and have not been independently verified.
Profile compiled from information published on the clinic's own website and from the Stem Cell Directory directory record. Details may change; confirm directly with the clinic before making decisions.